13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 52 holding rows worth $323,082,299.
- Accession
- 0001214659-23-014980
- Filer
- CIK 1482416
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 52 entries on the cover page, a total value of $323,082,299 stated on the cover page (in dollars after the unit check, H1), rows summing to $323,082,299 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 168,809 | $33,939,049 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 516,981 | $25,668,107 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 509,000 | $18,451,250 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 81,606 | $18,432,347 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 58,226 | $16,656,712 | dollars as filed | |
| GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 36266G107 | Stock | 242,308 | $16,486,636 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 796,933 | $16,010,384 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 450,700 | $14,949,719 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 767,000 | $13,315,120 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 64,491 | $12,666,677 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 15,250 | $12,550,140 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 110,780 | $8,680,721 | dollars as filed | |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 568,294 | $8,552,825 | dollars as filed | |
| HEALTHCARE SVCS GROUP INC | 421906108 | COM | 810,307 | $8,451,502 | dollars as filed | |
| ORTHOFIX MED INC | 68752M108 | COM | 650,000 | $8,359,000 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 73,400 | $8,236,948 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 884,770 | $7,909,844 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 595,002 | $6,586,672 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 2,081,216 | $5,993,902 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 222,947 | $5,879,112 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 756,891 | $4,897,085 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,105,911 | $4,180,344 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 248,127 | $4,138,758 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 24,129 | $4,079,973 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 342,477 | $3,928,211 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 232,751 | $3,693,758 | dollars as filed | |
| Merrimack Pharmaceuticals Inc | 590328209 | Common / Ordinary Stock | 288,466 | $3,556,786 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 896,250 | $3,387,825 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 635,969 | $3,376,995 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 3,294,534 | $2,955,197 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 2,599,003 | $2,832,913 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 72,700 | $2,012,336 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 74,007 | $1,996,709 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 200,076 | $1,410,536 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 280,000 | $1,166,620 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 350,000 | $1,081,500 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 150,000 | $1,011,000 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 76,049 | $918,672 | dollars as filed | |
| SIGHT SCIENCES INC | 82657M105 | COMMON STOCK | 246,699 | $831,376 | dollars as filed | |
| MODULAR MED INC | 60785L207 | COM NEW | 689,352 | $799,648 | dollars as filed | |
| HARPOON THERAPEUTICS INC | 41358P205 | COM | 168,017 | $677,109 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 246,036 | $639,694 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R200 | SPON ADS NEW | 254,150 | $477,802 | dollars as filed | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 97,616 | $421,701 | dollars as filed | |
| INOGEN INC | 45780L104 | COM | 52,794 | $275,585 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 130,000 | $167,700 | dollars as filed | |
| MOLECULIN BIOTECH INC | 60855D200 | COMMON | 271,230 | $115,951 | dollars as filed | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 102,049 | $103,069 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 400,000 | $69,800 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 30,741 | $65,171 | dollars as filed | |
| Humacyte Inc W Exp 08/27/202 | 44486Q111 | SPAC Combination | 49,998 | $33,439 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 12,808 | $2,369 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-23-014980 | this filing | 2023-11-14 | acceptance time not in the bulk data set |